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EDITORIAL COMMENT

Cardiogenic Shock Management Should
Be a Team Sport*
Perwaiz M. Meraj, MD,a William W. O’Neill, MDb

T

he advent of percutaneous mechanical reper-

and when escalation of care up to and including

fusion therapy of acute myocardial infarction

emergency

(AMI) in the 1980s (1) instilled the organiza-

indicated. For this reason, creation of shock teams

tion of medical care to be a series of sequential trade

consisting of ED physicians, interventional cardiolo-

off of responsibilities from emergency department

gists, cardiac ventricular assist device transplant

(ED) physician to catheterization laboratory interven-

surgeons,

tional cardiologist to cardiac intensive care unit

cardiac intensivists, and palliative care specialists

(CICU) attending. This same mechanism was incorpo-

have been organized in many centers to optimize

rated into management of cardiogenic shock (CS). The

cardiogenic shock care (5-8).

ED physician identiﬁed shock, initiated vasopressor

cardiac

transplant

advanced

heart

is

failure

possible

and

cardiologists,

SEE PAGE 1309

therapy, and transferred the patient to the catheterization laboratory where the interventional cardiolo-

In this issue of the Journal, Papolos et al (9) discuss

gist treated the culprit vessel(s) and often inserted

the management and outcomes of CS as it relates to

an intra-aortic balloon pump. The patient was trans-

CICU care with or without shock teams from the

ferred to the CICU and patients either survived or

multicenter Critical Care Cardiology Trials Network.

did not. For the last 30 years, the management was

The authors are to be lauded for their focus on shock

the same and the results, a 50% mortality rate, have

teams and postdevice CICU care (10), because these 2

been the same (2-4). The advent of mechanical circu-

areas are of such importance to further survival of

latory support (MCS) devices, such as veno-arterial

patients in CS. From 2017 to 2019, over a 2-month

extracorporeal

Impella

period, the authors demonstrate that among the

(Abiomed), Tandem Heart (LivaNova), and combina-

1,242 CS admissions, 44% were at shock team centers,

tions of these MCS devices, has provided hope that

whereas 42% of sites had shock teams. Centers with

survival may be improved with more effective sup-

shock teams were more likely to use invasive hemo-

port. To optimally use these devices, the process of

dynamics, pulmonary artery catheters (PACs), and

care must evolve. No individual physician has the

advanced forms of MCS; however, overall, fewer

experience and background to perform complex PCI,

patients received device therapy, mostly driven by

large bore access, vascular cut downs, antegrade

decreased use of the intra-aortic balloon pump.

sheath limb perfusion, surgical ventricular assist de-

Patient acuity was deﬁned by the SOFA (Sequential

vice placement, and rapid determination of whether

Organ Failure Assessment) score, and all invasive

membrane

oxygenator,

hemodynamics were recorded. Centers where venoarterial
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views of JACC or the American College of Cardiology.
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extracorporeal

membrane

oxygenator

is

managed in the cardiothoracic ICU were not followed,
which may lead to further confounding of the results,
although both groups had similar numbers of such

York, USA; and the bDepartment of Cardiology, Henry Ford Health Sys-

patients. Both AMI-CS and non–AMI-CS patients

tem, Detroit, Michigan, USA.

demonstrated improved mortality in CICU with shock

The authors attest they are in compliance with human studies commit-

teams compared with centers without shock teams.

tees and animal welfare regulations of the authors’ institutions and Food
and Drug Administration guidelines, including patient consent where
appropriate. For more information, visit the Author Center.

Inverse probability weighting was used to reduce
confounders inherent in any observational analysis.
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Papolos et al (9) expanded on the previously

reducing events of distal ischemia; however, close

reported evidence, which demonstrated improved

monitoring of limb ischemia in the CICU is of utmost

survival from years 1 to 2 after the development of the

importance (14,15). Many procedural techniques and

shock team (8,11), by demonstrating the 28% lower

novel CICU models exist to mitigate the risk of ALI in

adjusted odds of CICU mortality among CS patients in

CS patients with MCS (16,17). Finally, escalation of

centers with shock teams. PAC utilization was

care and support is vital to the continued success of

signiﬁcantly higher among centers with shock teams

any shock team and center (18).

(60% vs 49%) and was placed much earlier in the

Although many critics will continue to discuss the

patient’s course (0.3 days vs 0.66 days). The combi-

lack of randomized controlled trials in the ﬁeld of CS,

nation of increased PAC use and more advanced MCS

this paper supports the process previously outlined of

use appears to lead to the lower CICU mortality in

a multidisciplinary team-based approach improving

both AMI and non-AMI CS. Although this is observa-

survival. Establishing shock teams and CICUs that are

tional data, it supports the prior evidence to date

based in centers dedicated to CS is the path to

where presence of a shock team can rapidly identify

improved survival. Post-MCS care is of the utmost

and treat patients in CS, prevent the multisystem

importance to escalate appropriately if patients are

organ failure that contributes to worse mortality, and

not improving and avoid ALI, which are typically fatal

decrease the need for renal replacement therapy and

in these extremely ill patients. The continued support

prolonged ventilation (7,8), and increased use of PAC

for shock teams is vital to the improvement in care

leads to improved experience in interpreting, devel-

models and survival while the randomized data on

oping a treatment algorithm, and escalating care

MCS use in CS continues to be developed.

based on the data obtained (12,13).
An area not addressed in this paper is both esca-
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